Brief: CNS Pharmaceuticals Reports Q1 Results
May 14 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS - NET LOSS FOR 3 MONTHS ENDED MARCH
31,
2021 WAS ABOUT $3.6 MILLION COMPARED TO ABOUT $2.0 MILLION FOR
COMPARABLE PERIOD IN 2020
Source text for Eikon: ID:nPn2C2L41a
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026